Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Inflammatory responses predict long-term mortality risk in community-acquired pneumonia.

Guertler C, Wirz B, Christ-Crain M, Zimmerli W, Mueller B, Schuetz P.

Eur Respir J. 2011 Jun;37(6):1439-46. doi: 10.1183/09031936.00121510. Epub 2010 Nov 11.

2.

Clinical risk scores and blood biomarkers as predictors of long-term outcome in patients with community-acquired pneumonia: a 6-year prospective follow-up study.

Alan M, Grolimund E, Kutz A, Christ-Crain M, Thomann R, Falconnier C, Hoess C, Henzen C, Zimmerli W, Mueller B, Schuetz P; ProHOSP study group.

J Intern Med. 2015 Aug;278(2):174-84. doi: 10.1111/joim.12341. Epub 2015 Jan 27.

3.

Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study.

Johnstone J, Eurich DT, Majumdar SR, Jin Y, Marrie TJ.

Medicine (Baltimore). 2008 Nov;87(6):329-34. doi: 10.1097/MD.0b013e318190f444.

4.

Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia.

Lee JH, Kim J, Kim K, Jo YH, Rhee J, Kim TY, Na SH, Hwang SS.

J Crit Care. 2011 Jun;26(3):287-94. doi: 10.1016/j.jcrc.2010.10.007. Epub 2010 Dec 3.

PMID:
21129911
5.

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

Christ-Crain M, Morgenthaler NG, Stolz D, Müller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, Müller B.

Crit Care. 2006;10(3):R96. Epub 2006 Jun 28.

6.

Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Aujesky D, Auble TE, Yealy DM, Stone RA, Obrosky DS, Meehan TP, Graff LG, Fine JM, Fine MJ.

Am J Med. 2005 Apr;118(4):384-92.

PMID:
15808136
7.
8.

Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.

Bello S, Fandos S, Lasierra AB, Mincholé E, Panadero C, Simon AL, Gavin O, De Pablo F, Menendez R, Torres A.

Respir Med. 2015 Sep;109(9):1193-206. doi: 10.1016/j.rmed.2015.07.003. Epub 2015 Jul 14.

9.

Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.

Yang Y, Xu F, Shi LY, Diao R, Cheng YS, Chen XY, Jing JY, Wang XD, Shen HH.

Chin Med J (Engl). 2012 Feb;125(4):639-45.

PMID:
22490488
10.

Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.

Krüger S, Ewig S, Kunde J, Hartmann O, Suttorp N, Welte T; CAPNETZ Study Group.

Thorax. 2010 Mar;65(3):208-14. doi: 10.1136/thx.2009.121178.

PMID:
20335288
11.

Development of a prognostic index for 90-day mortality in patients discharged after admission to hospital for community-acquired pneumonia.

Capelastegui A, España PP, Quintana JM, Bilbao A, Menendez R, Zalacain R, Torres A.

Thorax. 2009 Jun;64(6):496-501. doi: 10.1136/thx.2008.098814. Epub 2009 Feb 22.

PMID:
19237392
12.

PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.

Rello J, Rodriguez A, Lisboa T, Gallego M, Lujan M, Wunderink R.

Crit Care Med. 2009 Feb;37(2):456-62. doi: 10.1097/CCM.0b013e318194b021.

PMID:
19114916
13.

Obesity paradox in patients with community-acquired pneumonia: Is inflammation the missing link?

Braun N, Hoess C, Kutz A, Christ-Crain M, Thomann R, Henzen C, Zimmerli W, Mueller B, Schuetz P.

Nutrition. 2017 Jan;33:304-310. doi: 10.1016/j.nut.2016.07.016. Epub 2016 Aug 9.

PMID:
27742103
14.

Cause-specific long-term mortality rates in patients recovered from community-acquired pneumonia as compared with the general Dutch population.

Bruns AH, Oosterheert JJ, Cucciolillo MC, El Moussaoui R, Groenwold RH, Prins JM, Hoepelman AI.

Clin Microbiol Infect. 2011 May;17(5):763-8. doi: 10.1111/j.1469-0691.2010.03296.x. Epub 2010 Aug 30.

15.

COPD is associated with increased mortality in patients with community-acquired pneumonia.

Restrepo MI, Mortensen EM, Pugh JA, Anzueto A.

Eur Respir J. 2006 Aug;28(2):346-51. Epub 2006 Apr 12.

16.

Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.

Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, Cocina BR, Alvarez F, Gorostidi J, Orejas C; ASTURPAR Group.

J Infect. 2009 Jun;58(6):417-24. doi: 10.1016/j.jinf.2009.03.003. Epub 2009 Mar 14.

PMID:
19329187
18.

Prospective evaluation of pneumonia severity index in hospitalised patients with community-acquired pneumonia.

van der Eerden MM, de Graaff CS, Bronsveld W, Jansen HM, Boersma WG.

Respir Med. 2004 Sep;98(9):872-8.

PMID:
15338800
19.

Admission D-dimer can identify low-risk patients with community-acquired pneumonia.

Chalmers JD, Singanayagam A, Scally C, Hill AT.

Ann Emerg Med. 2009 May;53(5):633-8. doi: 10.1016/j.annemergmed.2008.12.022. Epub 2009 Feb 7.

PMID:
19201061
20.

[Long-term survival of immunocompetent patients older than 60 years hospitalized for community-acquired pneumonia].

Saldías P F, Maturana O R, Román O F, Díaz P O.

Rev Med Chil. 2013 Jul;141(7):831-43. doi: 10.4067/S0034-98872013000700002. Spanish.

Supplemental Content

Support Center